The health ministry is expected to cut the official price of the drug by up to 15% from the current level of about ¥3 million ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing.

Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...

A promising new study from the Knight Family DIAN-TU research group at Washington University School of Medicine has found that starting Alzheimer’s treatment years before symptoms begin could delay — ...

Dr. Nicholas Milano of Medical University of SC says medications such as Lecanemab and donanemab give Alzheimer's patients new hope through MUSC's SCAN program ...

Eli Lilly has won a green light from the FDA for new dosing for its Alzheimer's disease therapy Kisunla, which carries a ...

With promising drugs in the pipeline, we are on the cusp of "turning the tide" against Alzheimer's. But President Trump's plan to slash research spending could delay or halt progress for years, ...

A recent study of patients who developed bipolar disorder or depression later in life revealed that half had high ...

Two breakthrough Alzheimer's drugs have been deemed far too expensive, for too little benefit, to be offered on the NHS. The ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for the future.

Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has said ...